Investors

Corporate Governance

Corporate Governance

Corporate Governance Overview

The Board of Directors of Kymera Therapeutics (the "Company") sets high standards for the Company's employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the Company's business. To fulfill its responsibilities and to discharge its duty, the Board of Directors follows the procedures and standards that are set forth in these guidelines. These guidelines are subject to modification from time to time as the Board of Directors deems appropriate in the best interests of the Company or as required by applicable laws and regulations.

Leadership Team

Please click here.

Committee Composition

Audit Committee Compensation Committee Nominating and Corporate Governance Committee
Jeff Albers Audit Committee Compensation Committee
Bruce Booth Nominating and Corporate Governance Committee
Steven Hall Compensation Committee
Andrew Hedin Audit Committee
Joanna Horobin Audit Committee Nominating and Corporate Governance Committee
Gorjan Hrustanovic Nominating and Corporate Governance Committee
Don Nicholson Compensation Committee
= Chairperson = Member